Finally, inhibition of SERCA degradation through the ubiquitin-proteasome system has been shown to rescue SERCA1 function in a cellular model of Brody disease [152], and therefore, it might also have therapeutic potential for LGMDR1. Here, CAPN3 is linked to Brody myopathy.